NEWSROOM

Press Releases
In the News
Logo & Resources Library

Recent News

News Update
Potential New Treatment in Phase III Trial
October 16, 2019
The Lupus Research Alliance is excited to announce that a potential new medicine for lupus—anifrolumab—reduced disease activity versus placebo...
News Update
Welcoming Daniel J. Wallace, MD to Lupus Therapeutics
October 16, 2019
The Lupus Research Alliance (LRA) affiliate Lupus Therapeutics is pleased to announce that Daniel J. Wallace, MD joins as...
News Update
Peer-to-Peer Involvement Advances Scientific Exploration
October 16, 2019
Many dynamics of lupus contribute to the fact that its complexities have eluded the scientific community—but new hope may...
News Update
Lupus Therapeutics Shifting the Paradigm
October 16, 2019
The Lupus Research Alliance (LRA)—going bold and thinking big—has once again shifted the status quo of lupus research by...
News Update
10 Lupus Therapeutics Studies Currently Underway
October 6, 2019
TAK-079A Study to Evaluate the Safety of TAK-079 PAISLEY-SLEA Phase II study to evaluate a novel, oral therapy in SLE ORKIDSA...
Press Release
Dr. Daniel Wallace Appointed to Lupus Therapeutics Board
July 18, 2019
The Lupus Research Alliance (LRA) affiliate Lupus Therapeutics is pleased to announce that Daniel Wallace, MD joins as a...
Press Release
Lupus Therapeutics Expands Collaboration with Bristol-Myers Squibb to Test Potential Treatment for Lupus
June 27, 2019
The Lupus Research Alliance (LRA) and its affiliate, Lupus Therapeutics, announced that it has broadened its collaboration with Bristol-Myers...
News Update
Lupus Research Alliance and Lupus Therapeutics – Leading Voices in Trial Diversity
June 25, 2019
Caroline Donovan, Manager of Patient Engagement at Lupus Research Alliance (LRA) affiliate Lupus Therapeutics (LT) took part in a...
Press Release
VALUE Study Results Reported at EULAR
June 13, 2019
Results of the first clinical trial sponsored by the Lupus Research Alliance and conducted through its Lupus Clinical Investigators...
News Update
Taking Scientific Discovery: From Lab Bench to You
April 8, 2019
Making new and efficacious lupus therapies available to patients has long been a major focus of the Lupus Research Alliance,...
Press Release
Lupus Therapeutics Partners with Takeda to Test Potential Treatment for Lupus
March 1, 2019
The Lupus Research Alliance and its affiliate, Lupus Therapeutics announced a collaboration with Takeda Pharmaceutical Company Limited, to evaluate...
Press Release
Lupus Therapeutics Launches Peer Training Program to Help Patients Benefit from Clinical Trials
February 1, 2019
Today, Lupus Therapeutics, an affiliate of Lupus Research Alliance, is launching our Patient Advocates for Lupus Studies (PALS) program...